Approval · Notice of Compliance 25951 · 2021
TIBELLA: Notice of Compliance 25951
Issued May 28, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25951
- Date
- May 28, 2021
- Company
- BioSyent Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling update for the package insert
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TIBELLA | Not yet assigned | — |
Medicinal ingredients
- TIBOLONE 2.5 MG per TAB